Clinical Trial Update: Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the nutritional supplement VIUSID/ALZER in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VIUSID/ALZER

Snippet

Sponsor: Catalysis SL | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED